2016
DOI: 10.1590/1414-431x20165116
|View full text |Cite
|
Sign up to set email alerts
|

Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats

Abstract: Supraphysiological administration of anabolic androgenic steroids has been linked to increased blood pressure. The widely distributed amino acid taurine seems to be an effective depressor agent in drug-induced hypertension. The purpose of this study was to assess the impact of chronic high dose administration of nandrolone decanoate (DECA) and taurine on blood pressure in rats and to verify the potentially involved mechanisms. The study was conducted in 4 groups of 8 adult male Wistar rats, aged 14 weeks, trea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
9
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 35 publications
(62 reference statements)
0
9
0
Order By: Relevance
“…Exogenous androgens in high dosages and/or prolonged administration have been shown to be atherogenic, by inducing ample changes in the lipid profile (increasing low-density lipoprotein-LDL cholesterol, triglycerides and apolipoprotein-B, and decreasing high-density lipoprotein-HDL cholesterol and apolipoprotein-A 1 ) [ 5 , 105 , 106 , 107 , 108 , 109 ], by increasing plasma homocysteine level [ 110 , 111 ], and by enhancing inflammation and oxidative stress at the endothelial level, with a consecutive reduction in NO synthesis [ 111 , 112 , 113 , 114 ]. AAS have also been shown to elevate blood pressure [ 111 , 112 , 115 ] and to induce hemorheological effects, through impairing vascular reactivity [ 105 , 111 ] and triggering a polycythemia-induced hyperviscosity syndrome (an intrinsic anabolic effect) [ 16 , 36 , 105 ]. Since the abovementioned altered parameters have been independently linked to various coagulation abnormalities (they lead to enhanced platelet adhesion and aggregation, activation of the coagulation cascade, and suppression of fibrinolysis [ 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 ]), it may be assumed that AAS abuse is prone to produce atherothrombotic phenomena also by influencing these cardiovascular risk markers.…”
Section: Overview Of Thrombogenic Potential Of Exogenous Androgensmentioning
confidence: 99%
“…Exogenous androgens in high dosages and/or prolonged administration have been shown to be atherogenic, by inducing ample changes in the lipid profile (increasing low-density lipoprotein-LDL cholesterol, triglycerides and apolipoprotein-B, and decreasing high-density lipoprotein-HDL cholesterol and apolipoprotein-A 1 ) [ 5 , 105 , 106 , 107 , 108 , 109 ], by increasing plasma homocysteine level [ 110 , 111 ], and by enhancing inflammation and oxidative stress at the endothelial level, with a consecutive reduction in NO synthesis [ 111 , 112 , 113 , 114 ]. AAS have also been shown to elevate blood pressure [ 111 , 112 , 115 ] and to induce hemorheological effects, through impairing vascular reactivity [ 105 , 111 ] and triggering a polycythemia-induced hyperviscosity syndrome (an intrinsic anabolic effect) [ 16 , 36 , 105 ]. Since the abovementioned altered parameters have been independently linked to various coagulation abnormalities (they lead to enhanced platelet adhesion and aggregation, activation of the coagulation cascade, and suppression of fibrinolysis [ 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 ]), it may be assumed that AAS abuse is prone to produce atherothrombotic phenomena also by influencing these cardiovascular risk markers.…”
Section: Overview Of Thrombogenic Potential Of Exogenous Androgensmentioning
confidence: 99%
“…Taurine is a “semi-essential”, ubiquitous sulfur-containing amino acid in mammalian tissues, with important physiological functions such as: bile salts synthesis, regulation of intracellular Ca 2+ concentration, anti-oxidative, osmoregulating, anti-inflammatory, anti-apoptotic, and cyto-protective actions [9,10,11]. Multiple human and animal studies have highlighted the role of taurine in cardiovascular disease prevention through various beneficial actions, such as cardioprotection, blood pressure regulation, hemostasis modulation, delay of atherogenesis, obesity prevention, protection against diabetes mellitus, and its complications [12,13,14,15]. Taurine has antiatherogenic properties that are provided through several mechanisms: it lowers cholesterol and homocysteine levels, stimulates bile salts synthesis, alleviates endothelial dysfunction, inhibits proatherogenic functions of monocytes, inhibits cell proliferation and prevents blood vessel remodeling [10,14,16].…”
Section: Introductionmentioning
confidence: 99%
“…It has been also recorded that taurine exerted preventive effects on experimental type II diabetic nephropathy, through decreasing blood glucose, improving lipid metabolism and stabilizing glomerular basement membrane structure [17] . Additionally, Rosca et al, (2016) stated that taurine had the ability to protect against AAS induced hypertension [18] .…”
Section: Introductionmentioning
confidence: 99%